Constantine Davides
Stock Analyst at Citizens JMP
(0.10)
# 4,628
Out of 4,683 analysts
175
Total ratings
37.1%
Success rate
-12%
Average return
Main Sectors:
Stocks Rated by Constantine Davides
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NRC NRC Health | Maintained: Buy | $23 → $26 | $22.00 | +18.18% | 2 | Jul 29, 2026 | |
| OMDA Omada Health | Maintained: Buy | $21 → $27 | $23.96 | +12.69% | 3 | Jul 20, 2026 | |
| HQY HealthEquity | Maintained: Buy | $122 → $111 | $104.42 | +6.30% | 9 | Jun 1, 2026 | |
| PGNY Progyny | Maintained: Buy | $30 → $31 | $26.37 | +17.56% | 8 | May 11, 2026 | |
| USPH U.S. Physical Therapy | Maintained: Buy | $113 → $98 | $78.27 | +25.21% | 6 | May 8, 2026 | |
| ADUS Addus HomeCare | Maintained: Buy | $150 → $142 | $120.71 | +17.64% | 8 | May 6, 2026 | |
| OPCH Option Care Health | Maintained: Buy | $38 → $32 | $24.04 | +33.11% | 17 | Apr 30, 2026 | |
| AMN AMN Healthcare Services | Maintained: Buy | $22 → $24 | $34.24 | -29.91% | 18 | Feb 23, 2026 | |
| WAY Waystar Holding | Maintained: Buy | $48 → $34 | $24.17 | +40.67% | 3 | Feb 18, 2026 | |
| EVH Evolent Health | Maintained: Buy | $11 → $10 | $4.92 | +103.25% | 14 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 → $24 | $7.75 | +209.68% | 14 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $31 | $21.07 | +47.13% | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $18.41 | n/a | 6 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $8.22 | n/a | 7 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $95.74 | n/a | 9 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $28.76 | n/a | 6 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $1.21 | n/a | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $0.3841 | n/a | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $0.7033 | n/a | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $31.77 | n/a | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $21.24 | n/a | 4 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.25 | $1.28 | n/a | 2 | Apr 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.0001 | n/a | 3 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8.5 | $2.64 | n/a | 1 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.3392 | n/a | 2 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $2.15 | n/a | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $33 | $0.725 | n/a | 3 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $68 | $0.616 | n/a | 1 | Oct 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $8 | $2.11 | n/a | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.25 | $1.64 | n/a | 1 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.3 | $0.57 | n/a | 1 | Aug 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $0.8683 | n/a | 1 | Mar 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $41 | $58.97 | n/a | 1 | Sep 27, 2011 |
NRC Health
Jul 29, 2026
Maintained: Buy
Price Target: $23 → $26
Current: $22.00
Upside: +18.18%
Omada Health
Jul 20, 2026
Maintained: Buy
Price Target: $21 → $27
Current: $23.96
Upside: +12.69%
HealthEquity
Jun 1, 2026
Maintained: Buy
Price Target: $122 → $111
Current: $104.42
Upside: +6.30%
Progyny
May 11, 2026
Maintained: Buy
Price Target: $30 → $31
Current: $26.37
Upside: +17.56%
U.S. Physical Therapy
May 8, 2026
Maintained: Buy
Price Target: $113 → $98
Current: $78.27
Upside: +25.21%
Addus HomeCare
May 6, 2026
Maintained: Buy
Price Target: $150 → $142
Current: $120.71
Upside: +17.64%
Option Care Health
Apr 30, 2026
Maintained: Buy
Price Target: $38 → $32
Current: $24.04
Upside: +33.11%
AMN Healthcare Services
Feb 23, 2026
Maintained: Buy
Price Target: $22 → $24
Current: $34.24
Upside: -29.91%
Waystar Holding
Feb 18, 2026
Maintained: Buy
Price Target: $48 → $34
Current: $24.17
Upside: +40.67%
Evolent Health
Jan 6, 2026
Maintained: Buy
Price Target: $11 → $10
Current: $4.92
Upside: +103.25%
Nov 7, 2025
Maintained: Buy
Price Target: $23 → $24
Current: $7.75
Upside: +209.68%
Nov 7, 2025
Maintained: Buy
Price Target: $30 → $31
Current: $21.07
Upside: +47.13%
Jul 15, 2025
Reiterated: Hold
Price Target: n/a
Current: $18.41
Upside: n/a
May 6, 2025
Maintained: Hold
Price Target: n/a
Current: $8.22
Upside: n/a
Apr 28, 2025
Reiterated: Hold
Price Target: n/a
Current: $95.74
Upside: n/a
Feb 25, 2025
Maintained: Hold
Price Target: n/a
Current: $28.76
Upside: n/a
May 25, 2023
Initiated Coverage: Buy
Price Target: $18
Current: $1.21
Upside: n/a
May 16, 2023
Maintained: Buy
Price Target: $19
Current: $0.3841
Upside: n/a
May 16, 2023
Reiterated: Buy
Price Target: $125
Current: $0.7033
Upside: n/a
May 11, 2023
Reiterated: Buy
Price Target: $15
Current: $31.77
Upside: n/a
May 10, 2023
Reiterated: Buy
Price Target: $23
Current: $21.24
Upside: n/a
Apr 18, 2023
Reiterated: Buy
Price Target: $5.25
Current: $1.28
Upside: n/a
Mar 30, 2023
Reiterated: Buy
Price Target: $6
Current: $0.0001
Upside: n/a
Mar 20, 2023
Initiated Coverage: Buy
Price Target: $8.5
Current: $2.64
Upside: n/a
Mar 16, 2023
Reiterated: Buy
Price Target: $6
Current: $0.3392
Upside: n/a
Feb 15, 2023
Reiterated: Buy
Price Target: $15
Current: $2.15
Upside: n/a
Dec 30, 2022
Maintained: Buy
Price Target: $50 → $33
Current: $0.725
Upside: n/a
Oct 18, 2022
Initiated Coverage: Buy
Price Target: $68
Current: $0.616
Upside: n/a
Sep 28, 2022
Maintained: Buy
Price Target: $14 → $8
Current: $2.11
Upside: n/a
Sep 23, 2022
Maintained: Buy
Price Target: $4.25
Current: $1.64
Upside: n/a
Aug 18, 2022
Maintained: Buy
Price Target: $2.3
Current: $0.57
Upside: n/a
Mar 14, 2022
Initiated Coverage: Buy
Price Target: $4
Current: $0.8683
Upside: n/a
Sep 27, 2011
Initiated Coverage: Buy
Price Target: $41
Current: $58.97
Upside: n/a